| All Releases |
|---|
 |
U.S. Patent Office Allows Another Significant VNUS Patent
May 9, 2008
|
10.2 KB |
|
| |
SAN JOSE, Calif., May 9 -- VNUS® Medical Technologies, Inc. today announced that the U.S. Patent & Trademark Office has decided to allow a second continuation patent application related to the patents in the VNUS patent infringement lawsuit against suppliers of endovenous laser products. This comes on the heels of the Patent Office's dec...
|
|
VNUS Medical Technologies to Present at Bank of America 2008 Health Care Conference
May 6, 2008
|
45.8 KB |
|
| |
SAN JOSE, Calif.—May 6, 2008--VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Bank of America 2008 Health Care Conference, to be held May 13-15, 2008, at the Four Seasons, Las Vegas, NV.
Read more
|
|
VNUS Medical Technologies, Inc. Announces Availability of Investor Presentation on Its IR Site
Apr 25, 2008
|
9.5 KB |
|
| |
SAN JOSE, Calif. - April 25, 2008 — VNUS Medical Technologies (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced that its investor presentation will be available on its corporate web site at http://ir....
|
|
First-Quarter 2008 Results Teleconference/Webcast for VNUS Medical Technologies Interrupted Due to Technical Difficulties
Apr 22, 2008
|
9.8 KB |
|
| |
SAN JOSE, Calif. -April 22, 2008 -- VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, explains interruption of its first-quarter 2008 teleconference and webcast held yesterday at 2:00 p.m. PT/5:00 p.m./ET. As a result of teleconfe...
|
|
VNUS Medical Technologies Reports First-Quarter 2008 Results: 21% Growth in Net Revenues and 51% Growth in Unit Sales
Apr 21, 2008
|
49.8 KB |
|
| |
SAN JOSE, Calif.-April 21, 2008 --VNUS® Medical Technologies, Inc. (Nasdaq:VNUS), a leading provider of medical devices for the minimally invasive treatment of venous disease, today announced its financial results for the first quarter ended March 31, 2008.
Net revenues for the first quarter of 2008 increased 21% to $18.9 million co...
|
|
VNUS Medical Technologies, Inc. Announces the Hiring of Don Todd as Vice President of Marketing
Apr 18, 2008
|
9.2 KB |
|
| |
SAN JOSE, Calif., April 18 -- VNUS® Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced the hiring of Don Todd as Vice President of Marketing. He will join the company on May 5, 2008.
Mr. Todd joins VNUS with over 20 year...
|
|
U.S. Patent Office Allows Significant New VNUS Patent
Apr 18, 2008
|
11.0 KB |
|
| |
SAN JOSE, Calif., April 18 -- VNUS® Medical Technologies, Inc. (Nasdaq: VNUS) today announced that the company has received a Notice of Allowability by the U.S. Patent & Trademark Office for a patent application that is a continuation of one of the three patents in the VNUS patent infringement lawsuit against suppliers of endoveno...
|
|
VNUS Medical Technologies to Report First-Quarter 2008 Results and Webcast Teleconference on April 21
Apr 7, 2008
|
10.1 KB |
|
| |
SAN JOSE, Calif. - April 7, 2008 -- VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the first quarter ended March 31, 2008, after the close of market on Ap...
|
|
Study Data Shows VNUS ClosureFAST™ Catheter More than 96% Effective
Feb 23, 2008
|
13.4 KB |
|
| |
Distinguished Physicians' Panel at American Venous Forum Presents Clinical Trial Results Confirming Efficacy, Greater Patient Comfort Than Laser
SAN JOSE, CALIF., February 23, 2008 - VNUS® Medical Technologies, Inc. (NASDAQ: VNUS), a worldwide leader in medical devices for the minimally invasive...
|
|
VNUS Medical Technologies Reports Fourth-Quarter 2007 Results: 54% Revenue Growth and Fourth Quarter Profitability
Feb 7, 2008
|
89.4 KB |
|
| |
VNUS Medical Technologies Reports Fourth-Quarter 2007 Results: 54% Revenue Growth and Fourth Quarter ProfitabilityVNUS Medical Technologies Reports Fourth-Quarter 2007 Results: 54% Revenue Growth and Fourth Quarter Profitability$20.6 Million Net Revenues, $0.05 Net Inc...
|
|
VNUS Medical Technologies to Report Fourth-Quarter 2007 Results and Webcast Teleconference on February 7
Jan 21, 2008
|
5.4 KB |
|
| |
SAN JOSE, Calif. - January 21, 2008 -- VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the fourth quarter ended December 31, 2007, after the close of market on Fe...
|
|
VNUS Medical Technologies Appoints Peter Osborne as Chief Financial Officer
Jan 18, 2008
|
4.8 KB |
|
| |
SAN JOSE, Calif. - January 18, 2008 - VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced the appointment of Peter Osborne as Chief Financial Officer and Vice President of Finance and Administration.
Mr. Osborne joins VNUS w...
|
|
New Trial Date Set for VNUS Medical Technologies, Inc. Patent Litigation
Jan 15, 2008
|
9.5 KB |
|
| |
San Jose, Calif. - January 15, 2008 - The patent infringement lawsuit brought by VNUS Medical Technologies, Inc. against three endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions, has been scheduled to start June 23, 2008. The jury trial is expected to last three to four weeks. VNUS is seeking an injunction and compensa...
|
|
VNUS Medical Technologies Appoints Kirti Kamdar as Senior Vice President of Research & Development
Dec 3, 2007
|
9.6 KB |
|
| |
*** Your Title Here ***
SAN JOSE, Calif. - December 3, 2007 - VNUS Medical Technologies, Inc. (Nas...
|
|
VNUS Medical Technologies to Present at Piper Jaffray 19TH Annual Health Care Conference
Nov 19, 2007
|
9.4 KB |
|
| |
SAN JOSE, Calif.-November 19, 2007--VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced its plans to present at the Piper Jaffray 19th Annual Health Care Conference, to be held November 27-29, 2007, at The Pierre Hotel in New York Ci...
|
|
Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Nov 14, 2007
|
11.1 KB |
|
| |
SAN JOSE, CALIF., November 14, 2007 - VNUS® Medical Technologies, Inc. (NASDAQ: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, announced that interim results from two multi-center studies using the VNUS ClosureFast catheter were presented today at the 34th Annual VEIT...
|
|
Physicians Hail VNUS Device for Closing Diseased Perforating Veins
Nov 1, 2007
|
11.3 KB |
|
| |
SAN JOSE, CALIF., November 1, 2007 – VNUS® Medical Technologies, Inc. (NASDAQ: VNUS), a worldwide leader in medical devices for the minimally invasive treatment of venous reflux disease, today announced the widespread success and rapid market growth of the VNUS ClosureRFS™ Stylet, an endovenous radiofrequency (RF) ablation cathete...
|
|
VNUS Medical Technologies Reports Third-Quarter 2007 Results:
47% growth in Net Revenues
Oct 29, 2007
|
41.8 KB |
|
| |
VNUS Medical Technologies Reports Third-Quarter 2007 Results:
47% growth in Net Revenues VNUS Medical Technologies Reports Third-Quarter 2007 Results:
47% growth in Net Revenues $17.5 Million Net Revenues, $0.14 Net Loss Per Share
SAN JOSE, Calif.-October 29, ...
|
|
Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion
Oct 22, 2007
|
9.5 KB |
|
| |
SAN JOSE, Calif. — October 22, 2007 — The start of the patent lawsuit by VNUS® Medical Technologies, Inc. (Nasdaq: VNUS) against three endovenous laser competitors, Diomed, AngioDynamics and Vascular Solutions, has been delayed from a previously scheduled start date of October 29. The delay is due to a busy court calendar. A co...
|
|
VNUS Medical Technologies to Report Third-Quarter 2007 Results and Webcast Teleconference on October 29
Oct 9, 2007
|
9.9 KB |
|
| |
SAN JOSE, Calif. - October 9, 2007 -- VNUS Medical Technologies, Inc. (Nasdaq: VNUS), a leading provider of medical devices for the minimally invasive treatment of peripheral vascular disease, announced today that it plans to report its financial results for the third quarter ended September 30, 2007, before market opens on October 29.
...
|
|
|
